[1]孙 龙,董致郅,王革生,等.凉血散瘀汤对高血压脑出血微创术后患者中医症候积分、神经功能缺损评分的影响[J].陕西中医,2023,(8):1061-1064.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.014]
　SUN Long,DONG Zhizhi,WANG Gesheng,et al.Effect of Liangxue Sanyu decoction on TCM syndrome scores,neurological deficit score of patients with hypertensive intracerebral hemorrhage after minimally invasive surgery[J].,2023,(8):1061-1064.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.014]
点击复制

凉血散瘀汤对高血压脑出血微创术后患者中医症候积分、神经功能缺损评分的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年8期
页码:
1061-1064
栏目:
临床研究
出版日期:
2023-08-05

文章信息/Info

Title:
Effect of Liangxue Sanyu decoction on TCM syndrome scores,neurological deficit score of patients with hypertensive intracerebral hemorrhage after minimally invasive surgery
作者:
孙 龙1; 董致郅1; 王革生2; 王 健3
(1.北京中医医院怀柔医院,北京 101400; 2.北京中医药大学东方医院神经外科,北京 100078; 3.长春中医药大学附属医院脑病中心,吉林 长春 130021)
Author(s):
SUN Long; DONG Zhizhi; WANG Gesheng; WANG Jian
(Beijing Huairou Hospital of Traditional Chinese Medicine,Beijing 101400,China)
关键词:
高血压脑出血;  凉血散瘀汤;  神经功能缺损;  日常生活能力量表;  中医症候积分
Keywords:
Hypertensive intracerebral hemorrhage;  Liangxue Sanyu decoction;  Neurological deficit;  Activity of daily living scale;  TCM syndrome score
分类号:
R 743.34
DOI:
DOI:10.3969/j.issn.1000-7369.2023.08.014
文献标志码:
A
摘要:
目的:探究凉血散瘀汤对高血压脑出血微创术后患者中医症候积分、神经功能缺损评分和日常生活能力量表(ADL)评分的影响。方法:按照随机数字表法将97例高血压脑出血微创术后患者分为两组,对照组(n=48)采用常规治疗,试验组(n=49)在常规治疗基础上加用凉血散瘀汤,比较两组疗效、中医症候积分、神经功能缺损评分以及ADL评分。结果:中药组治疗有效率97.96%高于对照组的83.33%(P<0.05); 两组治疗前中医症候积分、美国国立卫生院神经功能缺损量表(NIHSS)、ADL评分比较差异无统计学意义(均P>0.05); 中药组治疗后眩晕、头痛、心悸怔忡、胸闷中医症候积分较对照组低(均P<0.05); 中药组治疗后NIHSS评分较对照组低(P<0.05); 中药组治疗后ADL评分较对照组高(P<0.05)。结论:凉血散瘀汤治疗高血压脑出血微创术后患者可改善其中医症候,提高患者日常生活能力,改善神经功能缺损情况。
Abstract:
Objective:To investigate the effect of Liangxue Sanyu decoction on TCM syndrome scores,neurological deficit score and activity of daily living scale(ADL)score of patients with hypertensive intracerebral hemorrhage after minimally invasive surgery.Methods:97 patients with hypertensive intracerebral hemorrhage after minimally invasive surgery were divided into two groups according to random number table method.The control group(n=48)received conventional treatment,and the Chinese medicine group(n=49)was added with Liangxue Sanyu decoction on the basis of conventional treatment.Efficacy,TCM syndrome scores,neurological deficit score and ADL score were compared between the groups.Results:The treatment response rate in the Chinese medicine group was 97.96%,higher than 83.33% in the control group(P<0.05).There was no statistically significant difference in TCM syndrome scores,the national institutes of health stroke scale(NIHSS)score,ADL score between the two groups before treatment(all P>0.05).After treatment,TCM syndrome scores of dizziness,headache,palpitation and chest tightness in Chinese medicine group were lower than those in control group(all P<0.05).After treatment,NIHSS score of Chinese medicine group was lower than that of control group(P<0.05).After treatment,the ADL score of Chinese medicine group was higher than that of control group(P<0.05).Conclusion:Liangxue Sanyu decoction can improve the traditional Chinese medicine syndrome and neurological function defect of patients after minimally invasive surgery for hypertensive intracerebral hemorrhage,and improve patients' daily living ability.

参考文献/References:

[1] 曹 宁,王文涛.神经内镜下不同入路方式治疗高血压脑出血疗效及患者疾病近期预后比较[J].陕西医学杂志,2022,51(9):1106-1109.
[2] 夏 斌,李晓磊,王敏娟,等.动静脉畸形脑出血与高血压脑出血患者术后预后比较及影响因素分析[J].陕西医学杂志,2021,50(12):1528-1531.
[3] 李延喜,郭世文.微创手术对高血压基底节脑出血患者生活质量及脑功能恢复效果的影响研究[J].陕西医学杂志,2020,49(2):166-168,172.
[4] 叶 妮,王 钢,温大平,等.早期中医康复介入对脑出血患者功能及生活能力恢复的影响[J].陕西中医,2020,41(9):1205-1207.
[5] 佟 甜,张 聪,姜 秀,等.凉血散瘀汤加减联合羟苯磺酸钙治疗糖尿病视网膜病变患者的临床疗效症状积分及VEGF的影响[J].河北医学,2020,26(12):2094-2098.
[6] 中华医学会神经外科学分会,中国医师协会急诊医师分会,中华医学会神经病学分会脑血管病学组,等.高血压性脑出血中国多学科诊治指南[J].中国急救医学,2020,40(8):689-702.
[7] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:24-25.
[8] 国家中医药管理局脑病急症协作组.中风病诊断与疗效评定标准[J].北京中医药大学学报,1996,19(1):55-56.
[9] 陶子荣.我国脑卒中患者临床神经功能缺损评分标准信度、效度及敏感度的评价[J].第二军医大学学报,2009,30(3):283-285.
[10] 闵 瑜,吴媛媛,燕铁斌.改良Barthel指数(简体中文版)量表评定脑卒中患者日常生活活动能力的效度和信度研究[J].中华物理医学与康复杂志,2008,30(3):185-188.
[11] Ziai WC,Thompson CB,Mayo S,et al.Intracranial hypertension and cerebral perfusion pressure insults in adult hypertensive intraventricular hemorrhage:Occurrence and associations with outcome[J].Crit Care Med,2019,47(8):1125-1134.
[12] 陈洋洋,孙晓阳.小骨窗开颅血肿清除术治疗基底节区高血压脑出血的临床疗效分析[J].内蒙古医科大学学报,2020,42(2):181-184.
[13] 刘鹏程,罗有才,纪文军,等.立体定向-改良软通道微创介入颅内血肿清除术对高血压脑出血患者血清NSE、S100B、炎症因子水平及预后的影响[J].陕西医学杂志,2020,49(3):321-324,328.
[14] 张 杰,邢益桓,颜为国,等.高血压脑出血微创穿刺引流术后采用中医分阶段治疗方案的疗效评估[J].中医药导报,2021,27(1):86-90.
[15] 邱 游,李贤彬,顾 翔.益气活血化瘀汤联合常规治疗对高血压脑出血微创术后患者的临床疗效[J].中成药,2021,43(12):3339-3343.
[16] 李东峰,周国平,周文科,等.通腑醒神汤辅助神经内镜治疗高血压脑出血改善认知功能和凝血功能的价值[J].中华中医药学刊,2020,38(3):53-56.
[17] 郑 静,刘旭阳.凉血散瘀汤联合替米沙坦治疗肾虚血瘀型IgA肾病疗效及对肾脏纤维化的影响[J].现代中西医结合杂志,2018,27(32):3546-3549.
[18] 白金娟.凉血散瘀汤联合依达拉奉对脑出血患者血流动力学及神经功能的影响[J].实用中医内科杂志,2019,33(10):43-45.
[19] 苏晓红,赵亚军.凉血散瘀汤联合小牛血清去蛋白治疗脑出血急性期的疗效[J].临床医学研究与实践,2017,2(20):27-28.
[20] 燕 翔,吴咚咚.安宫牛黄丸联合尼莫地平治疗对高血压脑出血患者神经功能的影响[J].中华保健医学杂志,2022,24(2):159-161.
[21] 刘 念.自拟醒脑救神汤用于高血压性脑出血硬通道穿刺血肿引流术后的研究[D].济南:山东中医药大学,2010.
[22] 杨晓芸,张文波.基于CD40/NF-κB信号通路研究凉血散瘀汤在大鼠局灶性脑缺血再灌注损伤的保护作用[J].四川中医,2022,40(12):44-48.
[23] 李俊仙,苏宏兵.脑出血后缺血性脑损伤患者采用凉血散瘀汤联合尼莫地平的临床疗效[J].世界最新医学信息文摘,2019,19(65):204,208.
[24] 霍丽荣,张小健,周 平.凉血散瘀汤联合依达拉奉对脑出血患者神经功能缺损及骨桥蛋白表达的影响[J].四川中医,2017,35(5):134-136.
[25] 张丽敏,王坤红,王亚娟,等.凉血散瘀汤加减辅以醒脑开窍针刺联合微创穿刺引流治疗基底节脑出血的效果观察[J].天津中医药,2021,38(6):751-755.

相似文献/References:

[1]向广生,唐晨思,路博宇,等.凉血散瘀汤结合常规西药治疗IgA肾病疗效及对患者血液流变学、炎性细胞因子水平的影响[J].陕西中医,2024,(1):63.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.014]
　XIANG Guangsheng,TANG Chensi,LU Boyu,et al.Effects of Liangxue Sanyu decoction combined with conventional western medicine on hemorheology and inflammatory cytokine levels in patients with IgA nephropathy[J].,2024,(8):63.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.014]

备注/Memo

备注/Memo:
基金项目:国家中医药管理局国家中医临床基地业务建设科研专项课题(JDZX2015043)
更新日期/Last Update: 2023-08-10